Status:
ENROLLING_BY_INVITATION
CorEvitas Multiple Sclerosis (MS) Registry
Lead Sponsor:
CorEvitas
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for MS in a cohort of patients cared for by neur...
Detailed Description
The objective of the CorEvitas Multiple Sclerosis (MS) Registry is to create a national cohort of patients with MS. Data collected will be used to better characterize the natural history of the diseas...
Eligibility Criteria
Inclusion
- Has a diagnosis of MS at the time of enrollment.
- Age 18 years or older at the time of enrollment.
- Willing to provide Personal Information.
- Initiating (prescribed or starting) an Eligible Medication for the treatment of MS at the enrollment visit.
Exclusion
- 1\) Is participating or planning to participate in a double-blind randomized trial for an MS drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.
Key Trial Info
Start Date :
August 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2100
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03291756
Start Date
August 10 2017
End Date
December 1 2100
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CorEvitas, LLC
Waltham, Massachusetts, United States, 02451